Syndax Pharmaceuticals Inc
SNDX· Nasdaq
SNDXSyndax Pharmaceuticals Inc
Filed Aug 10, 2017 · 10-Q · 41 days after period end · 0001193125-17-254597
| Metric | Q2 2017 | Q2 2016 | Q2 2015 |
|---|---|---|---|
| Revenue | $305.00K | $305.00K | $17.00K |
| Net Income | -$13.64M | -$8.36M | -$6.21M |
| EPS Diluted | -$0.47 | -$0.47 | -$440.52 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Syndax Pharmaceuticals Inc · CIK 1395937 · Engraved from SEC EDGAR
ended Jun 30, 2017 · filed Aug 10, 2017 · 41 d after period end
